Anhui Anke BioTech Group Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Anhui Anke BioTech Group cash flow conversion efficiency. Based on the latest financial reports, Anhui Anke BioTech Group (300009) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥240.51 Million ≈ $35.19 Million USD) by net assets (CN¥4.34 Billion ≈ $635.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Anhui Anke BioTech Group (2006–2025)

Cash flow conversion efficiency of Anhui Anke BioTech Group from 2006 to 2025. This chart illustrates how Anhui Anke BioTech Group's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300009 stock price and chart for real-time trading data and today's change.

Anhui Anke BioTech Group Cash Flow Conversion Ratio Explained

Anhui Anke BioTech Group cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Anhui Anke BioTech Group Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Anke BioTech Group ranked by their cash flow conversion efficiency. Also see Anhui Anke BioTech Group market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Diebold Nixdorf, Incorporated NYSE:DBD	-0.021x
Grupo Profuturo S.A.B. de C.V MX:GPROFUT	0.044x
Dermapharm Holding SE XETRA:DMP	0.054x
Shilpa Medicare Limited NSE:SHILPAMED	0.083x
Transportadora de Gas del Sur SA B BA:TGSU2	0.102x
Bumitama Agri Ltd F:2BU	0.029x
Zhejiang Fulai New Material Co.Ltd. SHG:605488	0.025x
Snowline Gold Corp. V:SGD	N/A

Annual Cash Flow Conversion Efficiency for Anhui Anke BioTech Group (2006–2025)

The table below shows the annual cash flow conversion efficiency of Anhui Anke BioTech Group from 2006 to 2025. Review Anhui Anke BioTech Group free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥4.74 Billion ≈ $693.08 Million	CN¥863.22 Million ≈ $126.32 Million	0.182x	+14.34%
2024-12-31	CN¥4.30 Billion ≈ $629.22 Million	CN¥685.37 Million ≈ $100.29 Million	0.159x	-34.23%
2023-12-31	CN¥3.93 Billion ≈ $575.42 Million	CN¥952.97 Million ≈ $139.45 Million	0.242x	+17.94%
2022-12-31	CN¥3.40 Billion ≈ $497.77 Million	CN¥698.98 Million ≈ $102.28 Million	0.205x	+0.75%
2021-12-31	CN¥2.90 Billion ≈ $424.88 Million	CN¥592.17 Million ≈ $86.65 Million	0.204x	+28.50%
2020-12-31	CN¥2.93 Billion ≈ $428.54 Million	CN¥464.80 Million ≈ $68.01 Million	0.159x	+44.95%
2019-12-31	CN¥2.70 Billion ≈ $395.10 Million	CN¥295.63 Million ≈ $43.26 Million	0.109x	-23.41%
2018-12-31	CN¥2.01 Billion ≈ $294.29 Million	CN¥287.49 Million ≈ $42.07 Million	0.143x	-10.32%
2017-12-31	CN¥1.76 Billion ≈ $257.60 Million	CN¥280.63 Million ≈ $41.06 Million	0.159x	-11.88%
2016-12-31	CN¥1.43 Billion ≈ $208.70 Million	CN¥258.01 Million ≈ $37.75 Million	0.181x	+92.66%
2015-12-31	CN¥1.26 Billion ≈ $185.03 Million	CN¥118.73 Million ≈ $17.37 Million	0.094x	-33.17%
2014-12-31	CN¥773.47 Million ≈ $113.18 Million	CN¥108.68 Million ≈ $15.90 Million	0.141x	+74.44%
2013-12-31	CN¥660.60 Million ≈ $96.67 Million	CN¥53.21 Million ≈ $7.79 Million	0.081x	-13.16%
2012-12-31	CN¥580.03 Million ≈ $84.88 Million	CN¥53.80 Million ≈ $7.87 Million	0.093x	+602.56%
2011-12-31	CN¥543.88 Million ≈ $79.59 Million	CN¥7.18 Million ≈ $1.05 Million	0.013x	-85.46%
2010-12-31	CN¥522.30 Million ≈ $76.43 Million	CN¥47.43 Million ≈ $6.94 Million	0.091x	+16.32%
2009-12-31	CN¥495.41 Million ≈ $72.49 Million	CN¥38.67 Million ≈ $5.66 Million	0.078x	-55.44%
2008-12-31	CN¥148.64 Million ≈ $21.75 Million	CN¥26.04 Million ≈ $3.81 Million	0.175x	-31.56%
2007-12-31	CN¥137.09 Million ≈ $20.06 Million	CN¥35.10 Million ≈ $5.14 Million	0.256x	+5.30%
2006-12-31	CN¥122.00 Million ≈ $17.85 Million	CN¥29.66 Million ≈ $4.34 Million	0.243x	--

About Anhui Anke BioTech Group

SHE:300009 China Biotechnology

Market Cap

$1.97 Billion

CN¥13.45 Billion CNY

Market Cap Rank

#6027 Global

#1114 in China

Share Price

CN¥8.05

Change (1 day)

+1.13%

52-Week Range

CN¥7.50 - CN¥11.23

All Time High

CN¥127.71